Skip to content

Clinical trials

Lambert-Eaton Myasthenic Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lambert-Eaton Myasthenic Syndrome Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20101
20111
20121
20161
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available4
Approved for marketing3
Completed3
Recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Catalyst Pharmaceuticals, Inc.3
Addario Lung Cancer Medical Institute1
David P. Richman, MD1
Fred Hutchinson Cancer Center1
Jacobus Pharmaceutical1
Lahey Clinic1
Louis H. Weimer, MD1
Oregon Health and Science University1
Sanford Health1
The Cleveland Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lambert-Eaton Myasthenic Syndrome14
Myasthenia Gravis3
Myasthenic Syndromes, Congenital3
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating2
Addison Disease1
Alagille Syndrome1
Alstrom Syndrome1
Amnesia, Transient Global1
Amyotrophic Lateral Sclerosis1
Aniridia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.